The plant health solutions company's management, including Helash, plans to host an investor conference call at 4.30 pm ET (1.30 pm PT) on August 10 to reveal the results for the three months ended June 30, 2020. Registration can be done here.
“I am excited to join the team at Marrone Bio, and look forward to discussing the second quarter financial results with our shareholders on the August 10th conference call,” Helash said in a statement.
Helash will also join Marrone Bio’s board of directors on August 3.
A 28-plus-year agricultural industry veteran, Helash comes to Marrone Bio from Agrinos AS, a global-scale biological crop input provider specializing in biofertilizers and biostimulant products. As CEO of Agrinos since November 2017, he led a major restructuring and transformation of the company to create a platform for future long-term growth.
Helash replaces Pamela Marrone, founder of Marrone Bio, who announced her intention to retire as CEO in December 2019.
Based in Davis, California, Marrone Bio holds more than 400 issued and pending patents and has brought six US Environmental Protection Agency-registered biological product lines and one biostimulant to market.
Contact Andrew Kessel at email@example.com
Follow him on Twitter @andrew_kessel